Ergoteles LLC Relmada Therapeutics, Inc. Transaction History

Ergoteles LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$2.22 - $3.54 $60,162 - $95,934	27,100 New	27,100 $66,000
Q1 2022 May 13, 2022	SELL	$16.72 - $26.99 $1.53 Million - $2.47 Million	-91,500 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$16.93 - $26.82 $1.55 Million - $2.45 Million	91,500 New	91,500 $2.06 Million

12.3M

229K

138K

Ticker RLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,608,500
Market Cap $10.3M
Description
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.